Mullany Lila E, Wolff Roger K, Herrick Jennifer S, Buas Matthew F, Slattery Martha L
University of Utah, School of Medicine, Department of Internal Medicine, Salt Lake City, Utah, United States of America.
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
PLoS One. 2015 Dec 2;10(12):e0143894. doi: 10.1371/journal.pone.0143894. eCollection 2015.
MicroRNAs (miRNAs) regulate messenger RNAs (mRNAs) and as such have been implicated in a variety of diseases, including cancer. MiRNAs regulate mRNAs through binding of the miRNA 5' seed sequence (~7-8 nucleotides) to the mRNA 3' UTRs; polymorphisms in these regions have the potential to alter miRNA-mRNA target associations. SNPs in miRNA genes as well as miRNA-target genes have been proposed to influence cancer risk through altered miRNA expression levels.
MiRNA-SNPs and miRNA-target gene-SNPs were identified through the literature. We used SNPs from Genome-Wide Association Study (GWAS) data that were matched to individuals with miRNA expression data generated from an Agilent platform for colon tumor and non-tumor paired tissues. These samples were used to evaluate 327 miRNA-SNP pairs for associations between SNPs and miRNA expression levels as well as for SNP associations with colon cancer.
Twenty-two miRNAs expressed in non-tumor tissue were significantly different by genotype and 21 SNPs were associated with altered tumor/non-tumor differential miRNA expression across genotypes. Two miRNAs were associated with SNP genotype for both non-tumor and tumor/non-tumor differential expression. Of the 41 miRNAs significantly associated with SNPs all but seven were significantly differentially expressed in colon tumor tissue. Two of the 41 SNPs significantly associated with miRNA expression levels were associated with colon cancer risk: rs8176318 (BRCA1), ORAA 1.31 95% CI 1.01, 1.78, and rs8905 (PRKAR1A), ORGG 2.31 95% CI 1.11, 4.77.
Of the 327 SNPs identified in the literature as being important because of their potential regulation of miRNA expression levels, 12.5% had statistically significantly associations with miRNA expression. However, only two of these SNPs were significantly associated with colon cancer.
微小RNA(miRNA)可调控信使RNA(mRNA),因此与包括癌症在内的多种疾病有关。miRNA通过miRNA 5'种子序列(约7 - 8个核苷酸)与mRNA 3'非翻译区(UTR)结合来调控mRNA;这些区域的多态性有可能改变miRNA - mRNA的靶标关联。有人提出,miRNA基因以及miRNA靶基因中的单核苷酸多态性(SNP)可通过改变miRNA表达水平来影响癌症风险。
通过文献鉴定miRNA - SNP和miRNA靶基因 - SNP。我们使用了全基因组关联研究(GWAS)数据中的SNP,这些SNP与通过安捷伦平台生成的结肠癌肿瘤组织和非肿瘤配对组织的miRNA表达数据相匹配的个体。这些样本用于评估327对miRNA - SNP,以研究SNP与miRNA表达水平之间的关联以及SNP与结肠癌的关联。
在非肿瘤组织中表达的22种miRNA因基因型存在显著差异,21个SNP与不同基因型间肿瘤/非肿瘤miRNA差异表达的改变有关。两种miRNA在非肿瘤组织和肿瘤/非肿瘤差异表达中均与SNP基因型相关。在与SNP显著相关的41种miRNA中,除7种外,其余在结肠肿瘤组织中均有显著差异表达。与miRNA表达水平显著相关的41个SNP中有两个与结肠癌风险相关:rs8176318(BRCA1),优势比(OR)为1.31,95%置信区间(CI)为1.01, 1.78;以及rs8905(PRKAR1A),OR为2.31,95% CI为1.11, 4.77。
在文献中鉴定出的327个因可能调控miRNA表达水平而被认为重要的SNP中,12.5%与miRNA表达存在统计学显著关联。然而,其中只有两个SNP与结肠癌显著相关。